Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Radiological Investigation III: Pulmonary Angiogram and PET Scan01:13

Radiological Investigation III: Pulmonary Angiogram and PET Scan

713
Radiological investigations are paramount in the diagnosis and management of various pulmonary diseases. Two essential investigations are the Pulmonary Angiogram and the Positron Emission Tomography (PET) Scan.
Pulmonary Angiogram
A Pulmonary Angiogram is an invasive procedure involving injecting a contrast medium through a catheter threaded into the pulmonary artery or the right side of the heart to visualize the pulmonary vasculature. Computed Tomography (CT) scans have mainly replaced this...
713
Tumor Immunotherapy01:27

Tumor Immunotherapy

2.5K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
2.5K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Histological assessment of radiotherapy-induced injury in the anal canal: an exploratory study.

International journal of colorectal disease·2025
Same author

Does the benefit of neoadjuvant chemotherapy at six months predict long-term outcomes in colon or rectal cancer? A meta-analysis of randomised studies.

Cancer treatment reviews·2025
Same author

Standard versus reduced-dose chemoradiotherapy in anal cancer (PLATO-ACT4): short-term results of a phase 2 randomised controlled trial.

The Lancet. Oncology·2025
Same author

Evaluation of prognostic models to improve prediction of metastasis in patients following potentially curative treatment for primary colorectal cancer: the PROSPECT trial.

Health technology assessment (Winchester, England)·2025
Same author

Colorectal cancer para-aortic lymph node metastases: surgery should not be considered.

The British journal of surgery·2024
Same author

International Validation of the EORTC QLQ-ANL27, a Field Study to Test the Anal Cancer-Specific Health-Related Quality-of-Life Questionnaire.

International journal of radiation oncology, biology, physics·2022

Related Experiment Video

Updated: Apr 26, 2026

Pretargeted Radioimmunotherapy Based on the Inverse Electron Demand Diels-Alder Reaction
09:44

Pretargeted Radioimmunotherapy Based on the Inverse Electron Demand Diels-Alder Reaction

Published on: January 29, 2019

7.4K

Do t3 rectal cancers always need radiochemotherapy?

Rob Glynne-Jones1

  • 1Radiotherapy Department, Mount Vernon Centre for Cancer Treatment, Rickmansworth Road, Northwood, London, Middlesex, HA6 2RN, UK, Rob.glynnejones@nhs.net.

Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer
|August 9, 2014
PubMed
Summary
This summary is machine-generated.

For rectal cancer, advanced MRI can predict outcomes, potentially avoiding routine preoperative chemoradiation (CRT) in select cT3N0 cases. High-quality surgery (TME) significantly reduces local recurrence, making CRT omission feasible when the resection margin is clear.

More Related Videos

Robot-assisted Total Mesorectal Excision and Lateral Pelvic Lymph Node Dissection for Locally Advanced Middle-low Rectal Cancer
12:45

Robot-assisted Total Mesorectal Excision and Lateral Pelvic Lymph Node Dissection for Locally Advanced Middle-low Rectal Cancer

Published on: February 12, 2022

5.7K
Y-90 Radioembolization and PD-1 Inhibitor as Neoadjuvant Treatment in Hepatocellular Carcinoma
09:11

Y-90 Radioembolization and PD-1 Inhibitor as Neoadjuvant Treatment in Hepatocellular Carcinoma

Published on: May 24, 2024

1.7K

Related Experiment Videos

Last Updated: Apr 26, 2026

Pretargeted Radioimmunotherapy Based on the Inverse Electron Demand Diels-Alder Reaction
09:44

Pretargeted Radioimmunotherapy Based on the Inverse Electron Demand Diels-Alder Reaction

Published on: January 29, 2019

7.4K
Robot-assisted Total Mesorectal Excision and Lateral Pelvic Lymph Node Dissection for Locally Advanced Middle-low Rectal Cancer
12:45

Robot-assisted Total Mesorectal Excision and Lateral Pelvic Lymph Node Dissection for Locally Advanced Middle-low Rectal Cancer

Published on: February 12, 2022

5.7K
Y-90 Radioembolization and PD-1 Inhibitor as Neoadjuvant Treatment in Hepatocellular Carcinoma
09:11

Y-90 Radioembolization and PD-1 Inhibitor as Neoadjuvant Treatment in Hepatocellular Carcinoma

Published on: May 24, 2024

1.7K

Area of Science:

  • Oncology
  • Radiology
  • Surgical Oncology

Background:

  • Traditional TNM staging for rectal cancer using MRI and CT has limitations, particularly for cT3 tumors which show wide outcome variability.
  • Routine preoperative chemoradiation (CRT) is often given to cT3N0 patients despite advances in MRI for personalized risk assessment.
  • The efficacy of CRT in improving overall survival for rectal cancer remains questionable, while it increases morbidity.

Purpose of the Study:

  • To evaluate the necessity of routine preoperative chemoradiation (CRT) for cT3N0 rectal cancer patients.
  • To explore the role of advanced magnetic resonance imaging (MRI) in stratifying rectal cancer patients for personalized treatment.
  • To determine if high-quality surgical resection can obviate the need for CRT in select cases.

Main Methods:

  • Review of current practices in rectal cancer staging and treatment stratification.
  • Analysis of the impact of preoperative chemoradiation (CRT) on local recurrence, overall survival, and surgical morbidity.
  • Assessment of the predictive capabilities of magnetic resonance imaging (MRI) for individual patient outcomes.
  • Evaluation of the role of total mesorectal excision (TME) in managing local recurrence.

Main Results:

  • High-quality total mesorectal excision (TME) surgery is associated with low local recurrence rates (<10%), irrespective of preoperative radiotherapy.
  • Chemoradiotherapy (CRT) reduces local recurrence and can achieve tumor shrinkage but does not improve overall survival and increases surgical morbidity.
  • Advanced MRI can predict individual risks of recurrence, enabling more tailored treatment decisions.
  • CRT may be omitted in selected resectable cT3N0 rectal cancer cases when high-quality MRI and TME surgery are employed.

Conclusions:

  • Personalized risk stratification using advanced MRI can guide treatment decisions for rectal cancer.
  • High-quality TME surgery is crucial for minimizing local recurrence in rectal cancer.
  • Routine preoperative CRT may not be necessary for all cT3N0 rectal cancer patients, especially when resection margins are clear and TME is optimal.